Alderley Park Customer Story: BiVictriX

BiVictriX

Founded by Tiffany Thorne, BiVictriX is creating a pipeline of safer and more effective anti-cancer therapies with its unique therapeutic platform. Since its inception in 2017, Tiffany has successfully raised £2.3M investment for BiVictriX with help from Alderley Park’s Accelerator, and continues to develop its game-changing therapies. Take a look at how accessing the co-working lab at Bruntwood SciTech's Alderley Park provided this startup with the flexibility needed to grow without committing to large spends.

Watch the video below to find out more...